Abstract

Streptococcus agalactiae (group B streptococcus [GBS]) is a Gram-positive bacterium that was first recognized as a causative agent of bovine mastitis. S. agalactiae has subsequently emerged as a significant cause of human diseases. Here, we report the draft genome sequence of S. agalactiae PR06, which was isolated from a septicemic patient in a local hospital in Malaysia.

Highlights

  • Streptococcus agalactiae is a Gram-positive bacterium that was first recognized as a causative agent of bovine mastitis

  • S. agalactiae PR06 was grown in Todd-Hewitt broth under optimal growth conditions

  • A total of 67 contigs were produced, and these contigs were ordered with respect to the best-aligned positions compared to the reference genome of S. agalactiae A909 using Optimal Syntenic Layout of Unfinished Assemblies (OSLay) (4)

Read more

Summary

Introduction

Streptococcus agalactiae (group B streptococcus [GBS]) is a Gram-positive bacterium that was first recognized as a causative agent of bovine mastitis. Streptococcus agalactiae is well-adapted to asymptomatic colonization in the gastrointestinal and genitourinary tracts of healthy individuals (1). Under certain circumstances, it may turn into a life-threatening pathogen causing septicemia, meningitis, and pneumonia in neonates (2). It is a serious cause of mortality and morbidity in nonpregnant adults, particurly in elderly persons and those with underlying diseases (3).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.